Halkes PH - Search Results

1

Interpretation of ESPRIT in the FASTER trial.

Algra A, van Gijn J, Halkes PH, Kappelle LJ, Koudstaal PJ; ESPRIT Study Group. Algra A, et al. Among authors: halkes ph. Lancet Neurol. 2008 Mar;7(3):198-9; author reply 199. doi: 10.1016/S1474-4422(08)70030-9. Lancet Neurol. 2008. PMID: 18275919 No abstract available.

2

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.

ESPRIT Study Group; Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. ESPRIT Study Group, et al. Among authors: halkes ph. Lancet Neurol. 2007 Feb;6(2):115-24. doi: 10.1016/S1474-4422(06)70685-8. Lancet Neurol. 2007. PMID: 17239798 Clinical Trial.

3

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.

ESPRIT Study Group; Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. ESPRIT Study Group, et al. Among authors: halkes ph. Lancet. 2006 May 20;367(9523):1665-73. doi: 10.1016/S0140-6736(06)68734-5. Lancet. 2006. PMID: 16714187 Clinical Trial.

4

Large subcortical infarcts: clinical features, risk factors, and long-term prognosis compared with cortical and small deep infarcts.

Halkes PH, Kappelle LJ, van Gijn J, van Wijk I, Koudstaal PJ, Algra A. Halkes PH, et al. Stroke. 2006 Jul;37(7):1828-32. doi: 10.1161/01.STR.0000226993.88307.ff. Epub 2006 Jun 1. Stroke. 2006. PMID: 16741175

5

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.

VITATOPS Trial Study Group. VITATOPS Trial Study Group. Lancet Neurol. 2010 Sep;9(9):855-65. doi: 10.1016/S1474-4422(10)70187-3. Epub 2010 Aug 3. Lancet Neurol. 2010. PMID: 20688574 Free article. Clinical Trial.

6

Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.

Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, Navarro JC, Ranawaka UK, Uddin W, Ricci S, Gommans J, Schmidt R; VITATOPS trial study group. Hankey GJ, et al. Lancet Neurol. 2012 Jun;11(6):512-20. doi: 10.1016/S1474-4422(12)70091-1. Epub 2012 May 2. Lancet Neurol. 2012. PMID: 22554931 Free PMC article. Clinical Trial.

7

Prevention with low-dose aspirin plus dipyridamole in patients with disabling stroke.

Dippel DW, Maasland L, Halkes P, Kappelle LJ, Koudstaal PJ, Algra A; ESPRIT Study Group and the ESPS-2 Investigators. Dippel DW, et al. Stroke. 2010 Nov;41(11):2684-6. doi: 10.1161/STROKEAHA.110.586453. Epub 2010 Sep 30. Stroke. 2010. PMID: 20884870 Clinical Trial.

8

Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin.

Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A; European/Australasian Stroke Prevention in Reversible Ischaemia Trial Study Group. Halkes PH, et al. J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):437-9. doi: 10.1136/jnnp.2008.147918. J Neurol Neurosurg Psychiatry. 2009. PMID: 19289481

9

[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].

Algra A, De Schryver EL, Halkes PH. Algra A, et al. Among authors: halkes ph. Ned Tijdschr Geneeskd. 2008 May 17;152(20):1179; author reply 1180. Ned Tijdschr Geneeskd. 2008. PMID: 18549147 Dutch. No abstract available.

10

Oral anticoagulation in secondary prevention after cerebral ischemia of arterial origin.

Halkes PH; ESPRIT Study Group. Halkes PH, et al. Stroke. 2005 May;36(5):933. doi: 10.1161/01.str.0000163821.57159.e0. Stroke. 2005. PMID: 15867167 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page